Modern treatment strategies of cancer diseases aim at efficaciously modulating specific signaling and transcriptional pathways (for instance, VEGF antibodies [45], tyrosine kinase inhibitors for treating chronic lymphatic leukemia [46], or EGFR antibodies for treating advanced colon carcinoma) [47]. This evidence concerns the gene VEGFA and colon carcinoma.